Decomit HFA

Beximco manufactures wide range of products which includes decomit hfa. It belongs to respiratory products category. It is a metered dose inhaler (mdi) contains beclomethasone dipropionate. It is environment friendly inhaler which contains ozone-benign propellant replacing cfc propellant. It offers: decomit hfa is an advanced hfa formulation of beclomethasone dipropionate solution with an average particle size of 1.1 micron. The small extrafine particles achieved in decomit hfa results in greater drug deposition in the lungs, including the large, intermediate, and small airways, and less deposition in the oropharynx, greater drug deposition in the lungs is not associated with greater systemic side effects, decomit hfa because of having small particle size, effectively treats inflammation in the large, intermediate and small airways of the lungs, decomit hfa also ensures minimal drug deposition in the mouth and throat, etc.